Chris astle zymeworks
WebChris J. Astle. A thesis submitted to the Faculty of Graduate Studies and Research in partial fulfillment of the requirements for the degree of Master of Science, Dept. of … WebApr 12, 2024 · Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. About the company Rewards Price-To-Earnings ratio (4.8x) is below the US market (14.8x) Became profitable this year Risk Analysis
Chris astle zymeworks
Did you know?
WebAbout. Dr. Astle joined Zymeworks in April 2024 and currently serves as Senior Vice President and Chief Financial Officer. Prior to joining Zymeworks, Dr. Astle worked as a Chief Financial Officer at the CFO Centre in British Columbia, Canada from March 2024 to March 2024, and as Vice President, Finance at Alder BioPharmaceuticals Inc. in Seattle, … WebNov 14, 2024 · Chief Financial Officer at Zymeworks Published Nov 14, 2024 + Follow Published by Chris Astle Resident CFOat the Finance Director Magazine - November 13, 2024 Perhaps one of the most...
WebZymeworks Inc. 19,162 followers 1y We are thrilled to announce the promotion of Dr. Chris Astle to Senior Vice President and Chief Financial Officer! Chris brings a wealth of … WebZymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates.
WebFeb 24, 2024 · Chris joined the finance group at Zymeworks in 2024 after relocating from Seattle where he previously served as Vice President at Alder Pharmaceuticals (sold to … WebMay 4, 2024 · Zymeworks’ second clinical candidate, ZW49, is a novel bispecific HER2‑targeted antibody-drug conjugate currently in Phase 1 clinical development and combines the unique design and antibody ...
WebNov 14, 2024 · Chris Astle Chief Financial Officer at Zymeworks View articles by Chris Astle The CFO as strategist: from SMEs to… October 8, 2024 32 likes1 comment The …
WebMar 7, 2024 · VANCOUVER, British Columbia, March 07, 2024--Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel multifunctional biotherapeutics, today reported financial... group lavatoryWebOct 8, 2024 · Chris Astle Chief Financial Officer at Zymeworks Published Oct 8, 2024 + Follow CFOs are now contributing more than ever to corporate strategy in all sizes of organisation Published by... film eternity thailandWebNov 8, 2024 · Zymeworks is eligible to receive a $50 million upfront payment, ... financial position allows Zymeworks to properly fund and advance exciting opportunities in our product pipeline,” said Chris Astle, Ph.D., SVP and Chief Financial Officer. “With our cash runway potentially extended through at least 2026, and potentially beyond, we can focus ... group layers arcgis proWebZymeworks Inc (Zymeworks) is a clinical stage biopharmaceutical company that discovers, develops and commercializes biotherapeutics for the treatment of cancer, autoimmune … film eternity sub indoWebFeb 26, 2024 · Chris Astle Chief Financial Officer at Zymeworks Published Feb 26, 2024 + Follow Published by Chris Astle Resident CFO in the Finance Director Magazine - February 19, 2024. Co-authored... film ethan hawkeWebChris Astle is Sr VP/CFO at Zymeworks Inc. See Chris Astle's compensation, career history, education, & memberships. film ethan fromeWebMar 1, 2013 · View Chris Astle, P.Eng, PMP’S profile on LinkedIn, the world’s largest professional community. Chris has 8 jobs listed on their profile. See the complete profile … filme thanatomorphose